179 related articles for article (PubMed ID: 26124383)
1. Factors Predictive of Re-excision After Oncoplastic Breast-conserving Surgery.
Amabile MI; Mazouni C; Guimond C; Sarfati B; Leymarie N; Cloutier AS; Bentivegna E; Garbay JR; Kolb F; Rimareix F
Anticancer Res; 2015 Jul; 35(7):4229-34. PubMed ID: 26124383
[TBL] [Abstract][Full Text] [Related]
2. Short term safety of oncoplastic breast conserving surgery for larger tumors.
Wijgman DJ; Ten Wolde B; van Groesen NR; Keemers-Gels ME; van den Wildenberg FJ; Strobbe LJ
Eur J Surg Oncol; 2017 Apr; 43(4):665-671. PubMed ID: 28041648
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ.
Wei S; Kragel CP; Zhang K; Hameed O
Hum Pathol; 2012 Jul; 43(7):986-93. PubMed ID: 22221704
[TBL] [Abstract][Full Text] [Related]
4. The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy.
Mazouni C; Naveau A; Kane A; Dunant A; Garbay JR; Leymarie N; Sarfati B; Delaloge S; Rimareix F
Breast; 2013 Dec; 22(6):1189-93. PubMed ID: 24054903
[TBL] [Abstract][Full Text] [Related]
5. Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer.
Down SK; Jha PK; Burger A; Hussien MI
Breast J; 2013; 19(1):56-63. PubMed ID: 23301761
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing reoperation following breast-conserving surgery.
Philpott A; Wong J; Elder K; Gorelik A; Mann GB; Skandarajah A
ANZ J Surg; 2018 Sep; 88(9):922-927. PubMed ID: 29763991
[TBL] [Abstract][Full Text] [Related]
7. Non-menopausal Status, High Nuclear Grade, Tumor Size >30 mm and Positive Resection Margins Are Predictors of Residual Tumor After Lumpectomy for Ductal Carcinoma In Situ of the Breast.
Joste M; Mendes V; Tixier S; Palpacuer C; Laviolle B; Leveque J; Ouldamer L
Anticancer Res; 2015 Jun; 35(6):3471-7. PubMed ID: 26026112
[TBL] [Abstract][Full Text] [Related]
8. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
[TBL] [Abstract][Full Text] [Related]
9. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
10. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
Song HM; Styblo TM; Carlson GW; Losken A
Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
[TBL] [Abstract][Full Text] [Related]
11. Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma.
Wanis ML; Wong JA; Rodriguez S; Wong JM; Jabo B; Ashok A; Lum SS; Solomon NL; Reeves ME; Garberoglio CA; Senthil M
Am Surg; 2013 Oct; 79(10):1119-22. PubMed ID: 24160812
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Retrospective Analysis of Complications After Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia: Are These Procedures Equally Safe?
Imahiyerobo TA; Pharmer LA; Swistel AJ; Talmor M
Ann Plast Surg; 2015 Oct; 75(4):370-5. PubMed ID: 24691307
[TBL] [Abstract][Full Text] [Related]
13. Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive cases.
Kryh CG; Pietersen CA; Rahr HB; Christensen RD; Wamberg P; Lautrup MD
Breast; 2014 Dec; 23(6):784-9. PubMed ID: 25227964
[TBL] [Abstract][Full Text] [Related]
14. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF; Hu ES; Newman LA; Alderman AK
Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
[TBL] [Abstract][Full Text] [Related]
15. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
16. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
17. Resection margins and local recurrences in breast cancer: Comparison between conventional and oncoplastic breast conserving surgery.
Niinikoski L; Leidenius MHK; Vaara P; Voynov A; Heikkilä P; Mattson J; Meretoja TJ
Eur J Surg Oncol; 2019 Jun; 45(6):976-982. PubMed ID: 30795953
[TBL] [Abstract][Full Text] [Related]
18. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
19. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting successful breast conservation for ductal carcinoma in situ.
Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
